- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Amarillo Biosciences Inc+ Add to Watchlist
AMAR:US0.2240 USD 0.0010 0.44%
As of 20:10:02 ET on 05/27/2015.
Company Profile for Amarillo Biosciences Inc (AMAR)
Amarillo Biosciences, Inc. develops biologics for the treatment of human and animal diseases. The Company develops oral interferon alpha as a treatment for a variety of conditions, including Sjogren's syndrome, hepatitis B and C, and fibromyalgia syndrome.
Amarillo Biosciences Inc
Key Executives for Amarillo Biosciences Inc (AMAR)
|Stephen T Chen "Steve"Chairman/President/CEO/COO||Bernard CohenVP/CFO|